Literature DB >> 29500907

Alterations in gut microbial function following liver transplant.

Jasmohan S Bajaj1, Genta Kakiyama1, I Jane Cox2, Hiroshi Nittono3, Hajime Takei3, Melanie White1, Andrew Fagan1, Edith A Gavis1, Douglas M Heuman1, Ho Chong Gilles1, Phillip Hylemon1, Simon D Taylor-Robinson4, Cristina Legido-Quigley5, Min Kim5, Jin Xu5, Roger Williams2, Masoumeh Sikaroodi6, William M Pandak1, Patrick M Gillevet6.   

Abstract

Liver transplantation (LT) improves daily function and ameliorates gut microbial composition. However, the effect of LT on microbial functionality, which can be related to overall patient benefit, is unclear and could affect the post-LT course. The aims were to determine the effect of LT on gut microbial functionality focusing on endotoxemia, bile acid (BA), ammonia metabolism, and lipidomics. We enrolled outpatient patients with cirrhosis on the LT list and followed them until 6 months after LT. Microbiota composition (Shannon diversity and individual taxa) and function analysis (serum endotoxin, urinary metabolomics and serum lipidomics, and stool BA profile) and cognitive tests were performed at both visits. We enrolled 40 patients (age, 56 ± 7 years; mean Model for End-Stage Liver Disease score, 22.6). They received LT 6 ± 3 months after enrollment and were re-evaluated 7 ± 3 months after LT with a stable course. A significant improvement in cognition with increase in microbial diversity, increase in autochthonous and decrease in potentially pathogenic taxa, and reduced endotoxemia were seen after LT compared with baseline. Stool BAs increased significantly after LT, and there was evidence of greater bacterial action (higher secondary, oxo and iso-BAs) after LT although the levels of conjugated BAs remained similar. There was a reduced serum ammonia and corresponding rise in urinary phenylacetylglutamine after LT. There was an increase in urinary trimethylamine-N-oxide, which was correlated with specific changes in serum lipids related to cell membrane products. The ultimate post-LT lipidomic profile appeared beneficial compared with the profile before LT. In conclusion, LT improves gut microbiota diversity and dysbiosis, which is accompanied by favorable changes in gut microbial functionality corresponding to BAs, ammonia, endotoxemia, lipidomic, and metabolomic profiles. Liver Transplantation 24 752-761 2018 AASLD.
© 2018 by the American Association for the Study of Liver Diseases.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29500907      PMCID: PMC5992060          DOI: 10.1002/lt.25046

Source DB:  PubMed          Journal:  Liver Transpl        ISSN: 1527-6465            Impact factor:   5.799


  41 in total

1.  Cholesterol esters and atherosclerosis-a game of ACAT and mouse.

Authors:  L L Rudel; G S Shelness
Journal:  Nat Med       Date:  2000-12       Impact factor: 53.440

2.  Intestinal microbial metabolism of phosphatidylcholine: a novel insight in the cardiovascular risk scenario.

Authors:  Enzo Ierardi; Claudia Sorrentino; Mariabeatrice Principi; Floriana Giorgio; Giuseppe Losurdo; Alfredo Di Leo
Journal:  Hepatobiliary Surg Nutr       Date:  2015-08       Impact factor: 7.293

Review 3.  Bile salt biotransformations by human intestinal bacteria.

Authors:  Jason M Ridlon; Dae-Joong Kang; Phillip B Hylemon
Journal:  J Lipid Res       Date:  2005-11-18       Impact factor: 5.922

4.  A longitudinal systems biology analysis of lactulose withdrawal in hepatic encephalopathy.

Authors:  Jasmohan S Bajaj; Patrick M Gillevet; Neeral R Patel; Vishwadeep Ahluwalia; Jason M Ridlon; Birgit Kettenmann; Christine M Schubert; Masoumeh Sikaroodi; Douglas M Heuman; Mary M E Crossey; Debulon E Bell; Philip B Hylemon; Panos P Fatouros; Simon D Taylor-Robinson
Journal:  Metab Brain Dis       Date:  2012-04-12       Impact factor: 3.584

5.  Serum metabolic signature of minimal hepatic encephalopathy by (1)H-nuclear magnetic resonance.

Authors:  Beatriz Jiménez; Carmina Montoliu; David A MacIntyre; Miguel A Serra; Abdallah Wassel; María Jover; Manuel Romero-Gomez; Jose M Rodrigo; Antonio Pineda-Lucena; Vicente Felipo
Journal:  J Proteome Res       Date:  2010-10-01       Impact factor: 4.466

6.  Probiotic use in preventing postoperative infection in liver transplant patients.

Authors:  Yan Zhang; Jim Chen; Jinshan Wu; Helen Chalson; Lynn Merigan; Andrew Mitchell
Journal:  Hepatobiliary Surg Nutr       Date:  2013-06       Impact factor: 7.293

7.  Dietary diacylglycerol induces the regression of atherosclerosis in rabbits.

Authors:  Noriyasu Ota; Satoko Soga; Tadashi Hase; Ichiro Tokimitsu; Takatoshi Murase
Journal:  J Nutr       Date:  2007-05       Impact factor: 4.798

8.  Altered profile of human gut microbiome is associated with cirrhosis and its complications.

Authors:  Jasmohan S Bajaj; Douglas M Heuman; Phillip B Hylemon; Arun J Sanyal; Melanie B White; Pamela Monteith; Nicole A Noble; Ariel B Unser; Kalyani Daita; Andmorgan R Fisher; Masoumeh Sikaroodi; Patrick M Gillevet
Journal:  J Hepatol       Date:  2013-12-25       Impact factor: 25.083

9.  Metagenomic biomarker discovery and explanation.

Authors:  Nicola Segata; Jacques Izard; Levi Waldron; Dirk Gevers; Larisa Miropolsky; Wendy S Garrett; Curtis Huttenhower
Journal:  Genome Biol       Date:  2011-06-24       Impact factor: 13.583

10.  Precision microbiome reconstitution restores bile acid mediated resistance to Clostridium difficile.

Authors:  Charlie G Buffie; Vanni Bucci; Richard R Stein; Peter T McKenney; Lilan Ling; Asia Gobourne; Daniel No; Hui Liu; Melissa Kinnebrew; Agnes Viale; Eric Littmann; Marcel R M van den Brink; Robert R Jenq; Ying Taur; Chris Sander; Justin R Cross; Nora C Toussaint; Joao B Xavier; Eric G Pamer
Journal:  Nature       Date:  2014-10-22       Impact factor: 49.962

View more
  25 in total

Review 1.  Functional Microbiomics in Liver Transplantation: Identifying Novel Targets for Improving Allograft Outcomes.

Authors:  Michael Kriss; Elizabeth C Verna; Hugo R Rosen; Catherine A Lozupone
Journal:  Transplantation       Date:  2019-04       Impact factor: 4.939

Review 2.  Altered Microbiome in Patients With Cirrhosis and Complications.

Authors:  Chathur Acharya; Jasmohan S Bajaj
Journal:  Clin Gastroenterol Hepatol       Date:  2018-08-09       Impact factor: 11.382

Review 3.  Contribution of the Intestinal Microbiome and Gut Barrier to Hepatic Disorders.

Authors:  Daniel M Chopyk; Arash Grakoui
Journal:  Gastroenterology       Date:  2020-06-20       Impact factor: 22.682

Review 4.  Extrahepatic organs in the development of non-alcoholic fatty liver disease in liver transplant patients.

Authors:  Renyi Su; Xuyong Wei; Qiang Wei; Di Lu; Zuyuan Lin; Shuo Wang; Chuxiao Shao; Xiao Xu
Journal:  Hepatobiliary Surg Nutr       Date:  2022-06       Impact factor: 8.265

Review 5.  Promises of microbiome-based therapies.

Authors:  Jasmohan S Bajaj; Siew C Ng; Bernd Schnabl
Journal:  J Hepatol       Date:  2022-06       Impact factor: 30.083

6.  Bile Acid 7α-Dehydroxylating Gut Bacteria Secrete Antibiotics that Inhibit Clostridium difficile: Role of Secondary Bile Acids.

Authors:  Jason D Kang; Christopher J Myers; Spencer C Harris; Genta Kakiyama; In-Kyoung Lee; Bong-Sik Yun; Keiichi Matsuzaki; Megumi Furukawa; Hae-Ki Min; Jasmohan S Bajaj; Huiping Zhou; Phillip B Hylemon
Journal:  Cell Chem Biol       Date:  2018-10-25       Impact factor: 8.116

Review 7.  The gut microbiota in transplant patients.

Authors:  Pearlie P Chong; Andrew Y Koh
Journal:  Blood Rev       Date:  2019-08-29       Impact factor: 8.250

Review 8.  Chronic Liver Diseases and the Microbiome-Translating Our Knowledge of Gut Microbiota to Management of Chronic Liver Disease.

Authors:  Chathur Acharya; Jasmohan S Bajaj
Journal:  Gastroenterology       Date:  2020-11-28       Impact factor: 33.883

9.  Effect of liver transplantation on intestinal permeability and correlation with infection episodes.

Authors:  Francesca Romana Ponziani; Venanzio Valenza; Erida Nure; Giuseppe Bianco; Giuseppe Marrone; Antonio Grieco; Maurizio Pompili; Antonio Gasbarrini; Salvatore Agnes; Gabriele Sganga
Journal:  PLoS One       Date:  2020-06-26       Impact factor: 3.240

10.  Endotoxemia by Porphyromonas gingivalis Injection Aggravates Non-alcoholic Fatty Liver Disease, Disrupts Glucose/Lipid Metabolism, and Alters Gut Microbiota in Mice.

Authors:  Naoki Sasaki; Sayaka Katagiri; Rina Komazaki; Kazuki Watanabe; Shogo Maekawa; Takahiko Shiba; Sayuri Udagawa; Yasuo Takeuchi; Anri Ohtsu; Takashi Kohda; Haruka Tohara; Naoyuki Miyasaka; Tomomitsu Hirota; Mayumi Tamari; Yuichi Izumi
Journal:  Front Microbiol       Date:  2018-10-24       Impact factor: 5.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.